COL17A1 and chronic graft versus host disease: In chronic GvHD, B-cell dysregulation, including heightened B-cell receptor signaling and survival, may further drive the production of autoantibodies against BMZ proteins, such as BP180 and BP230 [26,33,34,35,36].